Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens ; volume:23 ; number:1 ; day:14 ; month:4 ; year:2023 ; pages:1-6 ; date:12.2023
BMC infectious diseases ; 23, Heft 1 (14.4.2023), 1-6, 12.2023
- Creator
-
Maggi, Paolo
Ricci, Elena Delfina
Cicalini, Stefania
Pellicanò, Giovanni Francesco
Celesia, Benedetto Maurizio
Vichi, Francesca
Cascio, Antonio
Sarchi, Eleonora
Orofino, Giancarlo
Squillace, Nicola
Madeddu, Giordano
Socio, Giuseppe Vittorio De
Bargiacchi, Olivia
Molteni, Chiara
Masiello, Addolorata
Saracino, Annalisa
Menzaghi, Barbara
Falasca, Katia
Taramasso, Lucia
Biagio, Antonio Di
Bonfanti, Paolo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-023-08191-2
- URN
-
urn:nbn:de:101:1-2023082809341507366099
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Maggi, Paolo
- Ricci, Elena Delfina
- Cicalini, Stefania
- Pellicanò, Giovanni Francesco
- Celesia, Benedetto Maurizio
- Vichi, Francesca
- Cascio, Antonio
- Sarchi, Eleonora
- Orofino, Giancarlo
- Squillace, Nicola
- Madeddu, Giordano
- Socio, Giuseppe Vittorio De
- Bargiacchi, Olivia
- Molteni, Chiara
- Masiello, Addolorata
- Saracino, Annalisa
- Menzaghi, Barbara
- Falasca, Katia
- Taramasso, Lucia
- Biagio, Antonio Di
- Bonfanti, Paolo
- SpringerLink (Online service)
Other Objects (12)
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Verfahren ARV
Vandrarnas arv
Rübenvorratsroder ARV
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort
Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment
ARV, 1.. Wegleitung
New ARV drugs
IV. Elevations
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Verfahren ARV
Vandrarnas arv
Rübenvorratsroder ARV
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort
Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment
ARV, 1.. Wegleitung
New ARV drugs
IV. Elevations
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam
Prevention of mother-to-child transmission of HIV in Zambia: implementing efficacious ARV regimens in primary health centers
Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
Verfahren ARV
Vandrarnas arv
Rübenvorratsroder ARV
Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi
Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort
Development of prediction model for alanine transaminase elevations during the first 6 months of conventional synthetic DMARD treatment
ARV, 1.. Wegleitung
New ARV drugs
IV. Elevations
Virological failure and predictors in patients with clinical and immunological failures to first-line ARV regimens in Vietnam